Lv2
108 积分 2023-06-08 加入
Efficacy, safety, and immunogenicity of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over three respiratory syncytial virus seasons (AReSVi-006): a multicentre, randomised, observer-blinded, placebo-controlled, phase 3 trial
19小时前
已完结
Conversion of vaccines from low to high immunogenicity by antibodies with epitope complementarity
19小时前
已完结
Next-generation nanovaccine induces durable immunity and protects against SARS-CoV-2
9天前
已完结
A respiratory syncytial virus (RSV) F protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domain
9天前
已完结
Evaluation of a recombinant five-antigen Staphylococcus aureus vaccine: The randomized, single-centre phase 1a/1b clinical trials
2个月前
已完结
A two-step dance commits collagen to folding
2个月前
已完结
An outcome-defining role for the triple-helical domain in regulating collagen-I assembly
2个月前
已完结
Type 1 collagen: Synthesis, structure and key functions in bone mineralization
2个月前
已完结
The safety and immunogenicity of a recombinant five-antigen Staphylococcus aureus vaccine among patients undergoing elective surgery for closed fractures: A randomized, double-blind, placebo-controlled, multicenter phase 2 clinical trial
2个月前
已完结
RSV Illness in the Young and the Old — The Beginning of the End?
4个月前
已完结
皖公网安备34019202002308
